UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055811
Receipt number R000063791
Scientific Title The effects of test meal intake on the intestinal environment
Date of disclosure of the study information 2024/10/12
Last modified on 2025/04/11 09:04:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of test meal intake on the intestinal environment

Acronym

The effects of test meal intake on the intestinal environment

Scientific Title

The effects of test meal intake on the intestinal environment

Scientific Title:Acronym

The effects of test meal intake on the intestinal environment

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To exploratorily evaluate the intestinal environment improvement effect on Japanese (20 to 59 years old) by intake of test food for four weeks.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Defecation frequency per week and intestinal microbiota analysis

Key secondary outcomes

Questionnaire (defecation, dietary records, physical condition),
Fecal moisture content, Fecal pH, Fecal putrefactive substances, Fecal short-chain fatty acids,
Urinary indoxyl sulfate levels corrected for creatinine
Body weight, BMI, Waist circumference


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake test meal three times a day before each meal, every day for four weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate
2.Persons who are Japanese and 20 years old or more and under 60 years old
3.Persons who tend to be constipated (defecation frequency: 2-5 times per week, with subjective symptoms of constipation)

Key exclusion criteria

1.Persons who have chronic illness, receiving medication, have a serious disease history
2.Persons who have a history of gastrointestinal surgery (excluding appendectomy or endoscopic polyp removal)
3.Persons who have or have a history of intestinal obstruction, esophageal stenosis, or abnormal intestinal narrowing
4.Persons who are allergic to the test food
5.Persons who are taking supplements containing dietary fiber
6.Persons who regularly take medicine (including laxatives), Chinese medicine, foods with health claims (foods for specified health uses, foods with functional claims, and foods with nutritional claims) that may affect the intestinal environment
7.Persons whose daily water intake is extremely low
8.Persons who have a habit of skipping meals
9.Persons who cannot prepare and consume the test food three times a day before each meal as instructed
10.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam
11.Persons who were judged as inappropriate for study participants by the principal investigator
12.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kazuma
Middle name
Last name Toda

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Park Place Bld. 5F, 5-27-1, Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Email

toda.kazuma@hc-sys.jp


Public contact

Name of contact person

1st name Kazuma
Middle name
Last name Toda

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

1050004

Address

Park Place 5F, 5-27-1 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

0368092722

Homepage URL


Email

toda.kazuma@hc-sys.jp


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

NISSIN FOODS HOLDINGS CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

1-14-18, Shirakane, Showa-ku, Nagoya, Aichi, JAPAN

Tel

03-6809-2722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 10 Month 02 Day

Date of IRB

2024 Year 10 Month 02 Day

Anticipated trial start date

2024 Year 10 Month 13 Day

Last follow-up date

2025 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 10 Month 11 Day

Last modified on

2025 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063791